Darryl Penenberg

Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse

Cora N. Sternberg, Alan Yagoda, Howard I. Scher et al. · Cancer · 1989 · 673 citations

Medicine, Oncology, Pharmacotherapy +14

nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial

David Goldstein, Robert H. El-Maraghi, Pascal Hammel et al. · JNCI Journal of the National Cancer Institute · 2015 · 663 citations

Medicine, Oncology, Pharmacology +14

RPC4046, a Monoclonal Antibody Against IL13, Reduces Histologic and Endoscopic Activity in Patients With Eosinophilic Esophagitis

Ikuo Hirano, Margaret H. Collins, Yehudith Assouline-Dayan et al. · Gastroenterology · 2018 · 267 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Prognostic factors for survival of patients with advanced urothelial tumors treated with methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy

Nancy L. Geller, Cora N. Sternberg, Darryl Penenberg et al. · Cancer · 1991 · 142 citations · Full text

Medicine, Oncology, Chemotherapy +7

Prognostic Factors of Survival in a Randomized Phase III Trial (MPACT) of Weekly <i>nab-</i>Paclitaxel Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Pancreatic Cancer

Josep Tabernero, E. Gabriela Chiorean, Jeffrey R. Infante et al. · The Oncologist · 2015 · 142 citations · Full text

Medicine, Oncology, Pharmacology +17